Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-15

FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves Teva's supplemental application for sotalol hydrochloride (generic). This action authorizes changes to the previously approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sotalol hydrochloride (sotalol hydrochloride)

Snippet

SUPPL AP for SOTALOL HYDROCHLORIDE (SOTALOL HYDROCHLORIDE)